Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 12, 2025CancersOpen Access

The Role of Epigenetic Biomarkers as Diagnostic, Predictive and Prognostic Factors in Colorectal Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

ZCZuzanna ChilimoniukKGKonrad GładyszNMNatalia Moniczewska

Discussion

Loading...

Member takes

Overview

Original studies reveal that epigenetic biomarkers enhance diagnostic accuracy in colorectal cancer, suggesting improved outcomes.

Key Points

  • Epigenetic biomarkers play a crucial role in diagnosing colorectal cancer, with DNA methylation showing high accuracy.
  • Multi-marker panels, especially those combining DNA methylation targets, provide better sensitivity for early colorectal cancer detection.
  • Certain microRNAs and DNA methylation markers predict treatment response and recurrence risk in colorectal cancer patients.
  • Despite promising findings, inconsistencies and lack of validation hinder the application of these biomarkers in clinical practice.

Cite This Study

Chilimoniuk et al. (2025) studied this question.

synapsesocial.com/papers/689e03e0d61984b91e13d083https://doi.org/10.3390/cancers17162632
View Full Paper
Ask AI
Bookmark
Share